Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maison Beljanski is a health and wellness company specializing in dietary supplements derived from the scientific research of French biologist Mirko Beljanski. The company focuses on the development and commercialization of natural botanical extracts, such as Pao pereira and Rauwolfia vomitoria, which are studied for their ability to support immune health and selectively target destabilized DNA. Their product portfolio includes specialized formulas like RealBuild, designed to support white blood cell and platelet production in patients undergoing chemotherapy. Maison Beljanski maintains a strong commitment to evidence-based natural medicine, collaborating with academic institutions to validate the efficacy of their compounds in oncology and integrative medicine. The company operates a flagship location in New York City and serves a global market through its specialized health products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maison Beljanski.